Out of 20 relapses that occurred in patients with Wegener's granulomatosis, nine were provoked by bacterial or viral infection. Seven of these occurred during maintenance treatment in response to infection with common pathogens, and treatment of the infection alone was insufficient to produce remission. Circulating immune complexes were seen only in relapses due to infection and rarely in infections that occurred without relapse. A possible mechanism for infection-provoked relapses is that infection-derived complexes reactivate disease; alternatively, the acute-phase or cellular response to infection may enhance quiescent disease.
Introduction
A study of patients being treated for antiglomerular basementmembrane disease identified intercurrent infection as an important cause of relapse and led to the recognition of infectioninduced enhancement of antibody-mediated injury.' Although its cause is still not clear, several mechanisms have been considered, including activation of inflammatory cells in response to infection, increased concentrations of acute-phase proteins such as fibrinogen and C-reactive protein, and the superimposition of infection-derived immune complexes. We report here on part of a prospective analysis of the effect of infection in autoallergic diseases, which investigated the importance of infection in relapses of Wegener's granulomatosis, a condition of uncertain aetiology but probably having an allergic pathogenesis of immune complex type. Enhanced tissue injury after infection has also been noted in other immunologically mediated diseases,2-8 and the possibility arises that exacerbation of allergic tissue damage by infection might be a more general phenomenon.
R S MITCHISON, MB, medical assistant phase"); patients were thereafter maintained with low-dose prednisolone and, after relapse, cyclophosphamide or azathioprine. Routine clinical, haematological, biochemical, bacteriological, virological, serological, and radiological tests were performed including regular microbiological sampling and assays for immune complex and C-reactive protein (at least three times a week during induction). In particular, a standard protocol of microbiological investigation of fever and other indicators of infection or of an unexplained increase in disease activity was used to identify possible infective organisms. This protocol included culture of blood, throat swabs, sputum, urine, surgical wounds, and other sites of infection; viruses were sought by direct sampling of lesions and urine cytology for viral inclusions as well as by viral serology; and bronchoscopic sampling and transbronchial biopsy were carried out to investigate unexplained parenchymal pulmonary shadowing. Circulating immune complexes were sought using a Cl q binding assay. 9 Infection was defined as a clinically identifiable episode in which the patient had symptoms or signs, or both, consistent with infection by the organism isolated or implicated and that could not be attributed to disease activity alone. Relapse was defined as evidence of recrudescence of or increase in the severity of symptoms or signs readily attributable to the underlying disease and not explicable in terms of infection alone. When relapse closely followed an acute reduction in drug treatment this was taken, for the purpose of the study, to be the precipitant. Relapses were crudely classified as "granulomatous"-manifested by pulmonary nodules or interstitial shadowing-or "vasculitic"-manifested by pulmonary haemorrhage (increase in diffusion factor for carbon monoxide corrected for alveolar volume and haemoglobin'0), nephritis, peripheral neuropathy, cerebral vasculitis, cutaneous vasculitis, episcleritis, and myopathy. For the purpose of analysing the association of relapse or infection, or both, with changes in circulating immune complexes and C-reactive protein we used only the results of the assays on a single serum sample, taken at the onset of the event. Statistical analysis was carried out using the ,'' test with Yates's correction.
Results
Of the 15 patients followed up, nine relapsed. Tables I and II show the events associated with the 20 relapses in these patients. relapse provoked pulmonary relapse, in addition to recrudescence of distant vasculitis in four patients and nephritis in two; a urinary infection and septicaemia led to exacerbation of nephritis. Furthermore, bacterial infection seemed to be followed most often by vasculitic relapse, though the numbers are too small for statistical analysis. During the induction of remission-that is, the first six to eight weeks of cyclophosphamide treatment and until steroids were reduced to baseline dosage-60 infections occurred, but only two of these caused recognisable exacerbation of disease activity; both were bacteraemias (two of the three identified). On the other hand, during maintenance treatment 15 infections were clinically apparent (many of them mild), of which seven were followed by relapse.
Circulating immune complexes, as detected by Clq binding, were found during five of the nine relapses associated with infection and none of the 10 relapses tested that were not associated with infection (X2 = 4 95, p < 0 05). Only four of the 46 infections not associated with relapse were accompanied by circulating immune complexes (x2= 8 90, p-0 01); two of these four were immediately consecutive infections in one patient and the other two occurred in a patient so ill from pulmonary infection that relapse could not have been diagnosed. Concentrations of C-reactive protein were raised in seven out of eight relapses tested that were associated with infection and in two out of nine relapses not associated with infection (X2= 4 86, p<0 05); raised concentrations were also found in 10 out of 44 other infections, not associated with-relapse (x2= 10-13, p<O-Ol).
In most instances relapse associated with infection was managed by treating both the infection and the relapse (by escalating treatment with steroids, cyclophosphamide, or azathioprine) concurrently. In two patients, however, treatment of the infection alone did not resolve the reactivated disease, which progre.,ed until specific treatment was started. The idea that the presence of complexes in the circulation may be due to defective clearance by the reticuloendothelial system is gaining ground, particularly after studies of splenic function in putative immune complex disease.'2 13 Some of our patients were found by Lockwood et al'2 to have defective splenic function during their initial disease, which was reversed by a plasma exchange regimen. The effect of infection on splenic reticuloendothelial function and its relation to the reappearance of circulating immune complexes in infectionprovoked relapse clearly warrant further study. A role for infection in the pathogenesis of Wegener's granulomatosis is further suggested by the observation that 10 of the 18 patients studied had a history of chronic suppurative infection of the respiratory tract, which long predated the vasculitic illness (A J Pinching et al); four of the five patients with infectionprovoked relapse had such a history.
Another possible mechanism for infection-provoked relapse is the enhancement of quiescent disease by the acute-phase or cellular response to infection: a limited amount of immunopathogenetic initiator (for example, circulating immune complex) may cause more tissue injury as a result of the provision of an increased supply of inflammatory mediators.
The phenomenon of infection-provoked enhancement of allergic tissue injury is seen in conditions of widely differing pathogenesis including autoantibody-mediated diseases such as antiglomerular basement-membrane disease ' 
Case report
A 55-year-old obese white man was admitted to hospital because of abdominal pain. He had been maintained on thrice weekly haemodialysis for two and a half years because of renal failure caused by nephrosclerosis. He had a history of duodenal ulcer, hiatus hernia, myocardial infarction, and angina pectoris. His medications included digoxin 0-25 mg every other day and nitroglycerin 0-4 mg sublingually as xLeeded.
Soon after starting haemodialysis he began to have severe recurrent, sustained, central, non-radiating abdominal pain brought on by physical exertion and relieved after 10-20 minutes by lying supine. The pain often occurred after dialysis, especially when he had required fluid removal in excess of two litres and had become hypotensive. The pain was never related to meals; and he had had no weight loss, diarrhoea, melaena, or rectal bleeding. Radiographs of the upper gastrointestinal tract and gall bladder were normal.
He was pale, sweating, and in great distress. The blood pressure was 100/60 mm Hg, and results of cardiac and respiratory examinations were normal. There was mild tenderness in the hypogastrium with no rebound tenderness, and the bowel sounds were active. Results of Hemoccult test of the stool were negative. His haemoglobin concentration was 13-3 g/dl, packed cell volume 0 4 (40 %), and peripheral blood leucocyte count 6-1 x 109/1 (6100/mm3). There was no biochemical or electrocardiographic evidence of new myocardial injury. A plain film of the abdomen showed a non-specific gas pattern and heavily calcified abdominal aorta and iliac vessels.
We suspected that the pain was due to mesenteric vascular disease, and abdominal angiography was planned after a trial of withholding treatment with digoxin. This lasted for the next five months, and though the dialysis regimen was unaltered the patient had no further abdominal pain. To test whether digoxin was the provocative agent the patient was rechallenged with digoxin, and recurrence of abdominal pain after dialysis was noted after 1-0 mg. Digoxin was again withdrawn, and he has since remained free of pain.
Comment
Intestinal angina is a syndrome of postprandial abdominal pain and weight loss associated with minimal physical findings. We believe that this case represents a variation of this syndrome and that the abdominal pain was a result of intestinal ischaemia, since it was induced by factors that either reduce cardiac output or cause splanchnic vasoconstriction-namely, contraction of the intravascular volume by rapid fluid removal during ultrafiltration-haemodialysis and physical exertion. Since digitalis acts as a direct splanchnic vasoconstrictor,3 relief of this patient's pain after discontinuing digoxin and the recurrence when rechallenged support the belief that the pain represented intestinal ischaemia that was exacerbated by digoxin.
A syndrome of digoxin-induced abdominal pain has not been reported in patients undergoing dialysis, many of whom take digitalis, have calcified aortas, and often undergo the stress of rapid fluid removal. To explain why this patient experienced pain and apparently similar patients do not is difficult. An additional predisposing factor for this patient was his packed cell volume, which was unusually high
